Breaking News, Financial News

Financial Report: Amgen 2Q

Total product sales for the quarter were $3.6 billion (-1%). Sales in the U.S. totaled $2.8 billion (-2%) and International sales were up 3% to $826 million.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Amgen 2Q 2Q Revenues: $3.8 billion (+3%) 2Q Earnings: $1.2 billion (-5%) YTD Revenues: $7.4 billion (+6%) YTD Earnings: $2.4 billion (+4%) Comments: Total product sales for the quarter were $3.6 billion (-1%). Sales in the U.S. totaled $2.8 billion (-2%) and International sales were up 3% to $826 million. U.S. product sales in the quarter include a $45 million unfavorable impact for certain U.S. Health Care Reform Legislation provisions. Worldwide sales of Aranesp were down 13% to...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters